Transgenomic’s European sales and support organization will market, sell and service the instruments. BioView’s products include the Duet, Allegro and Accord automated workstations for the scanning and classification of cells via fluorescence in-situ hybridization and brightlight microscopy.
The BioView products are intended for in-vitro diagnostic use as an aiding tool to the pathologist in the detection, classification and counting of cells of interest based on color, intensity, size, pattern and shape.
Craig Tuttle, president and CEO of Transgenomic, said: “We are very excited to add BioView’s world-leading imaging platforms to our cytogenetics portfolio of products. These sophisticated imaging systems will complement our Hanabi metaphase chromosome harvester and spreader products and further expand our sales and service reach into cytogenetics and pathology laboratories across Europe.”